US Patent Issued to Dragonfly Therapeutics on April 15 for "Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use" (Massachusetts, New Hampshire Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,791, issued on April 15, was assigned to Dragonfly Therapeutics Inc. (Waltham, Mass.).

"Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use" was invented by Gregory P. Chang (Medford, Mass.), Ann F. Cheung (Lincoln, Mass.), Daniel Fallon (Winchester, Mass.), Asya Grinberg (Lexington, Mass.), William Haney (Wayland, Mass.), Steven O'Neil (Wayland, Mass.), Nicolai Wagtmann (Concord, Mass.), Ronnie Wei (Weston, Mass.), Bradley M. Lunde (Lebanon, N.H.) and Bianka Prinz (Lebanon, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Multi-specific binding proteins that bind to and kill human cancer cells expressing epidermal ...